Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Multiple sklerose
by Most Patent Citation in the Japan in 2020

The Multiple sklerose top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Citation Multiple sklerose Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Multiple sclerosis is a progressive autoimmune disease that damages the insulating covers of brain cells. Depending on the brain region affected, it causes symptoms such as physical and mental dysfunction, fatigue, pain, depression, and anxiety [R+].
#
Company Name
Region
Tech Topics
Total
1
Diagnostic Reagent,Medicine,Health care,
...[+2]
patent citation: 278
2
patent citation: 115
3
patent citation: 50
4
patent citation: 44
5
patent citation: 32
6
patent citation: 31
7
Drug discovery,Gastrointestinal agent,Drug development,
...[+2]
patent citation: 25
8
Contract Manufacturing,Medicine,Chemical engineering,
...[+2]
patent citation: 23
9
patent citation: 19
10
patent citation: 16
11
patent citation: 12
12
Medicine,Health care,Clinical trial,
...[+2]
patent citation: 12
13
patent citation: 12
14
patent citation: 8
15
patent citation: 8
16
patent citation: 8
17
Cutamesine,Neuroregeneration,Medicine,
...[+2]
patent citation: 8
18
Drug,Clinical trial,Health care,
...[+2]
patent citation: 7
19
patent citation: 7
20
patent citation: 6
Page generation time: Jul 23 2025